海泰新光收盘上涨1.85%，滚动市盈率29.56倍，总市值42.44亿元

Core Insights - The stock price of Haitai Newlight closed at 35.19 yuan, up 1.85%, with a rolling PE ratio of 29.56, marking a 20-day low, and a total market capitalization of 4.244 billion yuan [1] - In the medical device industry, the average PE ratio is 48.90, with a median of 36.41, placing Haitai Newlight at the 66th position [1] - As of the first quarter of 2025, 26 institutions hold shares in Haitai Newlight, including 22 funds, 3 others, and 1 social security fund, with a total holding of 57.068 million shares valued at 2.145 billion yuan [1] Company Overview - Qingdao Haitai Newlight Technology Co., Ltd. specializes in the research, development, production, sales, and service of medical endoscope instruments and optical products [1] - The main products include high-definition fluorescence endoscope instruments, high-definition white light endoscope instruments, endoscope accessories, and endoscope maintenance services [1] - The company has achieved significant technological advancements in the field of medical endoscope instruments and optical products, holding 37 domestic and international invention patents and undertaking several key national and provincial science and technology projects [1] Financial Performance - For the first quarter of 2025, the company reported revenue of 147 million yuan, a year-on-year increase of 24.86%, and a net profit of 46.6887 million yuan, up 21.45%, with a gross profit margin of 64.98% [1]